Notice of Closed Meeting, 73020 [2023-23458]
Download as PDF
<![CDATA[
73020
Federal Register / Vol. 88, No. 204 / Tuesday, October 24, 2023 / Notices
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–23458 Filed 10–23–23; 8:45 am]
[FR Doc. 2023–23459 Filed 10–23–23; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Deputy
Director for Infectious Diseases
ddrumheller on DSK120RN23PROD with NOTICES1
Notice of Closed Meeting
Pursuant to 5 U.S.C section 1009(d),
notice is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
CE24–034, Rigorous Evaluation of
Policies for their Impacts on the Primary
Prevention of Multiple Forms of
Violence.
Date: February 27, 2024.
Time: 8 a.m.–5 p.m., EST.
Place: Web Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Carlisha Gentles, PharmD, BCPS,
CDCES, Scientific Review Officer,
National Center for Injury Prevention
and Control, CDC, 4770 Buford Highway
NE, Mailstop F–63, Atlanta, Georgia
30341, Telephone: (770)488–1504;
Email: CGentles@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
VerDate Sep<11>2014
17:08 Oct 23, 2023
Jkt 262001
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
Board of Scientific Counselors, Deputy
Director for Infectious Diseases (BSC,
DDID). This virtual meeting is open to
the public via Zoom, limited only by the
number of web conference lines
available (500 lines). Registration in
advance is required by accessing the
link below in the addresses section.
Time will be available for public
comment.
SUMMARY:
The meeting will be held on
November 30, 2023, from 1:30 p.m. to 3
p.m., EST.
ADDRESSES: Zoom virtual meeting.
Registration in advance is required by
accessing the link at https://
cdc.zoomgov.com/webinar/register/WN_
_r2EU3xBTB6MBiQq_HdqNQ.
Instructions to access the meeting will
be provided following registration.
FOR FURTHER INFORMATION CONTACT:
Sarah Wiley, MPH, Senior Advisor,
National Center for Emerging and
Zoonotic Infectious Diseases, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H16–5,
Atlanta, Georgia 30329–4037.
Telephone: (404) 639–4840; Email:
SWiley@cdc.gov.
SUPPLEMENTARY INFORMATION: Purpose:
The Board of Scientific Counselors,
Deputy Director for Infectious Diseases
(BSC, DDID) provides advice and
guidance to the Secretary, Department
of Health and Human Services; the
Director, Centers for Disease Control
and Prevention (CDC); and the Directors
DATES:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
of the National Center for Emerging and
Zoonotic Infectious Diseases, the
National Center for HIV, Viral Hepatitis,
STD, and TB Prevention, the National
Center for Immunization and
Respiratory Diseases, concerning
strategies, goals, and priorities for the
programs and research within the
national centers and monitors the
overall strategic direction and focus of
CDC’s infectious disease programs and
centers.
Matters To Be Considered: The agenda
will include updates and discussions on
recent outbreaks and disease
surveillance strategies, as well as a brief
report from one of the Board’s
workgroups: the Food Safety
Modernization Act Surveillance
Working Group. Agenda items are
subject to change as priorities dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–23460 Filed 10–23–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 5 U.S.C.
Section1009(d), notice is hereby given
of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\24OCN1.SGM
24OCN1
]]>Agencies
[Federal Register Volume 88, Number 204 (Tuesday, October 24, 2023)]
[Notices]
[Page 73020]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23458]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C section 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--CE24-034, Rigorous Evaluation of
Policies for their Impacts on the Primary Prevention of Multiple Forms
of Violence.
Date: February 27, 2024.
Time: 8 a.m.-5 p.m., EST.
Place: Web Conference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Carlisha Gentles, PharmD, BCPS,
CDCES, Scientific Review Officer, National Center for Injury Prevention
and Control, CDC, 4770 Buford Highway NE, Mailstop F-63, Atlanta,
Georgia 30341, Telephone: (770)488-1504; Email: [email protected].
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-23458 Filed 10-23-23; 8:45 am]
BILLING CODE 4163-18-P
